1. |
Castleman B, Towne VW. Case records of the Massachusetts General Hospital:Case No. 40231. N Engl J Med, 1954, 250(23):1001-1005.
|
2. |
Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9(4):822-830.
|
3. |
符刚, 田小波, 陈洁平, 等. 9例Castleman病临床观察及文献分析. 第三军医大学学报, 2013, 35(15):1636-1638.
|
4. |
Dispenzieri A, Armitage JO, Loe MJ, et al. The clinical spectrum of Castleman,s disease. Am J Hematol, 2012, 87(11):997-1002.
|
5. |
韩鸿雁, 李晓兵, 张博, 等. Castleman病临床病理分析并文献复习. 临床与实验病理学杂志, 2015, 31(1):58-61.
|
6. |
Zhu SH, Yu YH, Zhang Y, et al. Clinical features and outcome of patients with HIV-negative multicentric Castleman,s disease treated with combination chemotherapy:a report on 10 patients. Med Oncol, 2013, 30(1):492.
|
7. |
Uldrick TS, Polizzotto MN, Aleman KA, et al. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease:a pilot study of virus-activated cytotoxic therapy. Blood, 2011, 117(26):6977-6986.
|
8. |
Yuzuriha A, Saitoh T, Koiso H, et al. Successful treatment of autoim-mune hemolytic anemia associated with multicentric castleman disease by Anti-Interleukin-6 receptor antibody (tocilizumab) therapy. Acta Haematol, 2011, 126(3):147-150.
|
9. |
Van Rhee F, Wong RS, Munshi N, et al. Siltuximab for multicentric Castleman,s disease:a randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2014, 15(9):966-974.
|